SiNtx Technologies Inc (SINT)

[Freddrick123]

In Zimmer Biomet's Q1 2019 there is this:

On April 1, 2019, we entered into an agreement and paid $192.5 million to buy out certain licensing arrangements from an unrelated third party. This new
agreement and the related payment replace the variable royalty payments that otherwise would have been due under the terms of previous licensing arrangements
through 2029. Under the new agreement, we maintain the rights to the counterparty’s intellectual property provided under the previous licensing
arrangements. The $192.5 million payment will be recognized as an intangible asset and amortized through 2029, which represents the useful life of the intellectual
property.

If this were applicable to the Sintx and CTL deal what would that mean in regards to RS, who gets what cut of the 192.5mil, and spine ownership? I find it interesting that the deal is first day of Q2 specifically.

https://otp.tools.investis.com/clients/us/zimmer_biomet/SEC/sec-show.aspx?FilingId=13407066&Cik=0001136869&Type=PDF&hasPdf=1